We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$148M
AUM Growth
+$7.27M
Cap. Flow
+$7.5M
Cap. Flow %
5.05%
Top 10 Hldgs %
41.04%
Holding
73
New
3
Increased
35
Reduced
7
Closed
5

Top Buys

Rank Stock Value
1
TEAR
TearLab Corporation
TEAR
+$4.27M
2
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$3.69M
3
NEO icon
NeoGenomics
NEO
+$1.89M
4
ITMN
INTERMUNE INC
ITMN
+$1.28M
5
ATRC icon
AtriCure
ATRC
+$410K

Top Sells

Rank Stock Value
1
STKL
SunOpta
STKL
+$1.76M
2
MASI
Masimo
MASI
+$1.42M
3
OREX
Orexigen Therapeutics, Inc.
OREX
+$1.27M
4
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$986K
5
THOR
THORATEC CORPORATION
THOR
+$867K

Sector Composition

Rank Sector Weight
1 Healthcare 82.86%
2 Technology 2.4%
3 Consumer Staples 1.11%
4 Financials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
1
AtriCure
ATRC
$1.92B
$8.9M 6%
484,320
+24,611
+5% +$410K
AKRX
2
DELISTED
Akorn Inc
AKRX
$6.93M 4.67%
208,303
+10,347
+5% +$271K
NEO icon
3
NeoGenomics
NEO
$1.96B
$6.76M 4.56%
2,037,528
+568,450
+39% +$1.89M
SPNC
4
DELISTED
Spectranetics Corp
SPNC
$6.52M 4.39%
284,978
+14,044
+5% +$326K
TLGT
5
DELISTED
Teligent, Inc
TLGT
$6.34M 4.27%
119,432
+6,054
+5% +$309K
ENZ
6
DELISTED
Enzo Biochem, Inc.
ENZ
$5.83M 3.92%
1,109,616
+55,914
+5% +$242K
SRGA
7
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.68M 3.83%
43,539
+2,224
+5% +$282K
ARRY
8
DELISTED
Array Biopharma Inc
ARRY
$4.71M 3.17%
1,032,120
+55,321
+6% +$229K
LGND icon
9
Ligand Pharmaceuticals
LGND
$5.76B
$4.63M 3.12%
119,204
+6,734
+6% +$273K
HBIO icon
10
Harvard Bioscience
HBIO
$27.5M
$4.62M 3.11%
101,429
+5,279
+5% +$222K
OMCL icon
11
Omnicell
OMCL
$1.61B
$4.34M 2.93%
151,262
+8,264
+6% +$223K
TEAR
12
DELISTED
TearLab Corporation
TEAR
$4.26M 2.87%
+87,413
New +$4.27M
LCI
13
DELISTED
Lannett Company, Inc.
LCI
$4.14M 2.79%
20,873
-4,166
-17% -$655K
STRM
14
DELISTED
Streamline Health Solutions
STRM
$3.97M 2.67%
55,105
+4,463
+9% +$331K
VCRA
15
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$3.56M 2.4%
+270,078
New +$3.69M
STAA icon
16
STAAR Surgical
STAA
$1.21B
$3.44M 2.32%
204,617
+11,730
+6% +$193K
NVDQ
17
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.35M 2.26%
203,307
+9,857
+5% +$162K
TECH icon
18
Bio-Techne
TECH
$11.2B
$3.3M 2.23%
142,712
+7,008
+5% +$155K
ALKS icon
19
Alkermes
ALKS
$8.22B
$3.21M 2.16%
63,684
+3,429
+6% +$158K
OXFD
20
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.12M 2.1%
185,384
+10,037
+6% +$181K
SPPI
21
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2.99M 2.02%
367,890
+18,623
+5% +$141K
QDEL icon
22
QuidelOrtho
QDEL
$1.14B
$2.86M 1.93%
129,544
-30,118
-19% -$693K
NPSP
23
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$2.76M 1.86%
83,563
+4,464
+6% +$129K
NXTM
24
DELISTED
NxStage Medical Inc.
NXTM
$2.67M 1.8%
186,080
+10,425
+6% +$136K
CLDX icon
25
Celldex Therapeutics
CLDX
$2.99B
$2.27M 1.53%
9,290
+453
+5% +$102K
1
2 3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, First Light Asset Management held 73 positions worth $148M, up 5.1% from $141M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

First Light Asset Management deployed $7.5M of net new capital in Q2 2014, opening 3 new positions and adding to 35 existing holdings. Its largest new stake was TearLab Corporation: 87,413 shares worth $4.26M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 86% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was SunOpta, an estimated $1.76M trimmed.

  • First Light Asset Management's largest Q2 2014 buy was TearLab Corporation: 87,413 shares worth $4.26M.
  • First Light Asset Management added most to NeoGenomics in Q2 2014, an estimated $1.89M increase.
  • First Light Asset Management's biggest Q2 2014 reduction was SunOpta, cutting an estimated $1.76M.
  • First Light Asset Management fully exited Masimo in Q2 2014, selling an estimated $1.42M.
  • First Light Asset Management's ten largest holdings make up 41% of its $148M portfolio in Q2 2014.
  • First Light Asset Management opened 3 new positions and closed 5 in Q2 2014.
  • First Light Asset Management's portfolio value rose 5.1% quarter-over-quarter to $148M.

Based on First Light Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.